Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heterogeneity in cellular antigen retention structures.

S V Betancourt1, M J Solvay, D N Irani

  • 1Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor 48109.

Journal of Immunology (Baltimore, Md. : 1950)
|December 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for the Collective Nature of Radial Flow in Pb+Pb Collisions with the ATLAS Detector.

Physical review letters·2026
Same author

Evidence for the Dimuon Decay of the Higgs Boson in pp Collisions with the ATLAS Detector.

Physical review letters·2025
Same author

Evidence for Longitudinally Polarized W Bosons in the Electroweak Production of Same-Sign W Boson Pairs in Association with Two Jets in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Observation of tt[over ¯] Production in Pb+Pb Collisions at sqrt[s_{NN}]=5.02  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Dark Matter Produced in Association with a Dark Higgs Boson in the bb[over ¯] Final State Using pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2025
Same author

Search for Magnetic Monopole Pair Production in Ultraperipheral Pb+Pb Collisions at sqrt[s_{NN}]=5.36  TeV with the ATLAS Detector at the LHC.

Physical review letters·2025
Same journal

Optineurin restrains IL-17-associated neuroinflammation in trigeminal ganglia to preserve sensory function after ocular HSV-1 infection.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

Crystal structure and immune single-cell atlas provide insights into the functional divergence of type I IFNs in fish.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

Complement C3 deficiency increases the effector and cytotoxic functions of NK cells and suppresses tumor growth.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

Increased Nur77 is disconnected from TCR affinity in insulin-specific Tregs.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

FTR85 negatively regulates type I IFN antiviral signaling pathway by promoting K48-linked polyubiquitination of IRF3.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same journal

An MR1-specific nanobody capable of blocking MR1T cell activation.

Journal of immunology (Baltimore, Md. : 1950)·2026
See all related articles

Antigen-presenting cells (APCs) form membrane complexes with peptide antigens, independent of major histocompatibility complex class II molecules. This suggests diverse cell surface molecules may bind and present antigens to T cells.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Antigen presentation to T cells by antigen-presenting cells (APCs) is crucial for adaptive immunity.
  • The exact mechanisms and molecules involved in peptide antigen binding to APCs are not fully understood, particularly beyond major histocompatibility complex (MHC) class II molecules.

Purpose of the Study:

  • To investigate if other cell types and peptide antigens form membrane-bound complexes similar to the previously identified "peak A" complex.
  • To determine if MHC class II molecules are involved in the formation of these peptide-antigen complexes.

Main Methods:

  • Incubation of various murine cell lines with different antigenic peptides (angiotensin II, alpha-melanocyte-stimulating hormone, human fibrinopeptide B).
  • Analysis of membrane-bound complex formation ("peak A") and peptide degradation patterns.

Related Experiment Videos

  • Cross-inhibition studies to assess peptide specificity.

    • Main Results:

    • Multiple cell types form "peak A" membrane complexes with various peptide antigens, not solely limited to guinea pig macrophages or angiotensin II.
    • No evidence for the involvement of MHC class II molecules in the observed peptide binding.
    • Cell-specific differences in complex formation and peptide degradation suggest heterogeneity in peptide processing and retention.
    • Peptide specificity in "peak A" formation indicates potential molecular heterogeneity in the binding structures.

    Conclusions:

    • Cell surface molecules distinct from MHC class II can bind and retain peptide antigens.
    • This suggests a broader range of molecular interactions involved in antigen presentation to T cells.
    • Cellular heterogeneity influences peptide processing and presentation, contributing to immune response diversity.